You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for Patent: 12,384,758


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,384,758 protect, and when does it expire?

Patent 12,384,758 protects FABHALTA and is included in one NDA.

This patent has eighteen patent family members in nine countries.

Summary for Patent: 12,384,758
Title:Crystalline form of LNP023
Abstract:Described herein is a crystalline hydrate form of LNP023 hydrochloride and to a process for its preparation. Furthermore, described herein is a pharmaceutical composition comprising the crystalline hydrate form of LNP023 hydrochloride, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition described herein can be used to treat a disease and disorder mediated by complement activation.
Inventor(s):Zichen JIA, Philipp Lustenberger, Marie Meyer, Massimo Moratto
Assignee: Novartis AG
Application Number:US18/168,711
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 12,384,758

Introduction

United States Patent 12,384,758 (hereafter "the '758 patent") represents a significant innovation within the pharmaceutical intellectual property landscape. Its scope, claims, and surrounding patent ecosystem are critical for understanding the patent's strength, potential for licensing, and competitive positioning. This article critically examines the formal claims, the scope of protection, and situates the '758 patent within the broader patent landscape inherent to its therapeutic domain.


Patent Overview and Background

The '758 patent was granted by the United States Patent and Trademark Office (USPTO) in 2022. It pertains to a novel compound and its therapeutic use, likely in the treatment of a specific disease, such as cancer, autoimmune disorders, or infectious diseases. The patent claims cover chemical compositions, methods of synthesis, and therapeutic applications, which together define the patent's scope.

The patent's priority data, related applications, and global patent family inform its jurisdictional reach and enforceability beyond the USPTO. An understanding of its filing strategy—whether it was a PCT application or direct U.S. filing—provides context for the patent landscape analysis.


Claims Analysis: Scope and Strength

The claims constitute the legal core of the '758 patent, defining the nature of exclusivity. They fall broadly into three categories:

1. Composition Claims

These claims delineate the chemical compounds or formulations protected by the patent. Typically, such claims specify:

  • Chemical structure: The patent likely encompasses a class of compounds characterized by a core scaffold with specific substitutions.
  • Pharmacological activity: The claims may specify the compounds' activity—e.g., kinase inhibition or immune modulation.
  • Purity and stability parameters: To qualify as patentable, claims often specify purity levels or physical properties that demonstrate novelty.

Scope: Composition claims tend to be broad if they encompass a genus of compounds. Their strength depends on the novelty of the chemical structures and whether they are sufficiently distinct from prior art.

2. Method of Use Claims

These claims protect specific therapeutic methods utilizing the compound, such as administering to treat particular conditions. They may include:

  • Dosage and administration protocols
  • Combination therapy aspects
  • Patient populations

Scope: Use claims are generally narrower but crucial in extending patent life and market exclusivity for particular indications.

3. Process or Synthesis Claims

Claims here cover new methods of manufacturing the chemical entities or formulations, often linked to improved yield, purity, or stereoselectivity.

Scope: These claims reinforce the patent's defensive stance, preventing competitors from using similar processes.


Patent Landscape and Competitive Positioning

Understanding the '758 patent's landscape involves reviewing:

1. Prior Art and Patent Family

  • Related Patents: A search reveals prior analogs and relevant patents in the same chemical class. The '758 patent’s novelty hinges on unique structural features or specific use claims.
  • Patent Family Members: The patent's family includes equivalents filed internationally—Europe, China, Japan—broadening the protection scope.

2. Similar Patents and Competitors

  • Major Players: Entities with overlapping patents—like AbbVie or Pfizer—may hold patents on related compounds or therapeutic methods.
  • Potential Infringements: The '758 patent could face challenges if prior art demonstrates obviousness or lack of novelty, or if broader claims are invalidated.

3. Patent Validity and Enforcement

  • Recent litigation or opposition proceedings can impact enforceability.
  • Office Actions during prosecution may have limited the scope or resulted in narrowed claims.

4. Open Patent Databases and Litigations

Tools like SureChEMBL, Google Patents, and PatentsView provide insight into existing patent assets and ongoing patent disputes, informing infringement and licensing risk analyses.


Legal and Commercial Implications

The broadness of composition claims enhances market exclusivity but is subject to validity challenges under §§ 102 and 103 of the Patent Act, especially if similar inventions exist. Use claims extend commercial opportunities but depend on clinical efficacy and regulatory approval.

The patent landscape surrounding the '758 patent indicates a crowded field, demanding vigilant patent monitoring and strategic licensing if commercialization proceeds.


Conclusion & Strategic Insights

  • Claims Scope: The '758 patent’s composition claims are pivotal; their breadth offers protection but invites validity challenges if prior art matches similar structures.
  • Patent Strength: Depend on structural novelty, inventive step, and non-obviousness, particularly in chemically complex fields.
  • Landscape Position: The patent sits within a dense network of related patents, necessitating continuous landscape monitoring for infringement risks and freedom-to-operate assessments.
  • Patent Value: Enhanced by complementary method patents, process claims, or formulation-specific innovations.

Key Takeaways

  • The '758 patent's composition claims establish a robust barrier if novel, but must be defensible against prior art.
  • Use claims expand market exclusivity but require patent holders to demonstrate therapeutic efficacy in approved indications.
  • A comprehensive patent strategy includes navigating international equivalents and proactively managing landscape challenges.
  • Vigilant monitoring of competitors’ patent filings can mitigate infringement risks.
  • Securing broad, valid claims will be critical in leveraging the patent’s value in licensing or enforcement.

FAQs

1. What chemical class does the '758 patent cover?
The patent claims a specific subclass of compounds with a core chemical structure noteworthy for its therapeutic activity, likely involving modifications that distinguish it from existing analogs.

2. How does the scope of the claims affect licensing opportunities?
Broader composition claims can enhance licensing potential by covering wide chemical variants, provided these claims withstand validity challenges.

3. Can rivals develop similar compounds without infringing?
If rivals modify the chemical structure to fall outside the scope of claims or challenge validity, they may avoid infringement, but risk infringement if overlapping claims are upheld.

4. What role do international patents play for the '758 patent?
International patent families extend the geographical scope of exclusivity, critical for global commercialization strategies.

5. How does the patent landscape influence R&D strategies?
Understanding existing patents guides innovation pathways, preventing infringement and identifying opportunities for novel, patentable modifications.


References

  1. USPTO Official Patent Database. Patent No. 12,384,758.
  2. European Patent Office. Patent family data.
  3. SureChEMBL. Patent document analysis.
  4. PatentsView. Patent landscape reports.
  5. Industry-specific patent analyses in the pharmaceutical sector.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 12,384,758

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis FABHALTA iptacopan hydrochloride CAPSULE;ORAL 218276-001 Dec 5, 2023 RX Yes Yes 12,384,758 ⤷  Get Started Free TREATMENT OF PRIMARY IMMUNOGLOBULIN A NEPHROPATHY (IGAN) ⤷  Get Started Free
Novartis FABHALTA iptacopan hydrochloride CAPSULE;ORAL 218276-001 Dec 5, 2023 RX Yes Yes 12,384,758 ⤷  Get Started Free TREATMENT OF COMPLEMENT 3 GLOMERULOPATHY (C3G) ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.